Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy

Am J Cardiol. 2003 Feb 15;91(4):514-5; author reply 515. doi: 10.1016/s0002-9149(02)03291-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Coronary Disease / complications*
  • Coronary Disease / drug therapy*
  • Data Interpretation, Statistical
  • Diabetes Complications*
  • Eptifibatide
  • Humans
  • Peptides / pharmacology
  • Peptides / therapeutic use*
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Research Design / standards*
  • Treatment Outcome

Substances

  • Peptides
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Eptifibatide